Sarah L. Wicks Associate 202-900-2801
Sarah L. Wicks

Overview

Sarah L. Wicks assists clients with pre- and post-market FDA regulatory topics, including new drug and biologic development and approval issues, clinical trials operations and compliance matters, and Hatch-Waxman patent and exclusivity. Ms. Wicks also assists with FDA, DOJ, and DEA enforcement matters, state regulatory and licensing issues, and promotional material and labeling.

Ms. Wicks received her juris doctor degree from the University of Maryland with a concentration in intellectual property and health law. She also holds a Master of Public Health from Johns Hopkins School of Public Health where she focused on clinical trial regulations and ethics and earned the Pharmacoepidemiology and Drug Development Certificate. While in law school, Ms. Wicks interned at FDA’s Office of Generic Drugs Policy at the Center for Drug Evaluation and Research and Office of Legislation within the Office of Policy, Planning, Legislation, and Analysis

Work supervised by the Firm while DC Bar application is pending

Education & Admissions

Education

M.P.H., Johns Hopkins School of Public Health
Pharmacoepidemiology and Drug Development Certificate
J.D., Univeristy of Maryland School of Law
B.S. cum laude, Cell and Molecular Biology, Towson University

Admissions

Maryland

Speaking Engagements

  • University of Minnesota Rare Disease Day 2020, The Rare Disease Treatment Approval Process: Balancing Gold Standard Evidence with Patient-Centered Flexibility, February 28, 2020
  • University of Minnesota Rare Disease Day 2020,  Patient-Focused Drug Development: An Overview, February 28, 2020
Education

M.P.H., Johns Hopkins School of Public Health
Pharmacoepidemiology and Drug Development Certificate
J.D., Univeristy of Maryland School of Law
B.S. cum laude, Cell and Molecular Biology, Towson University

Admissions

Maryland

Practice Areas
Industries
FDA Regulatory Categories